Thursday, November 30, 2023
As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.
Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
Professor of Medicine
McMaster University
Hamilton, Ontario, Canada
Professor of Medicine and Biochemistry
McMaster University
Hamilton, Ontario, Canada
Professor of Cardiology and Angiology
Heart Center Freiburg University
Freiburg, Germany
Medscape, LLC staff have disclosed that they have no relevant financial relationships.
Peer Reviewer
This activity has been peer reviewed and the reviewer has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Abbott Laboratories.
This activity is intended for cardiologist, primary physicians, and surgeons.
The goal of this activity is to provide the latest information on the use of factor Xa inhibitors in preventing further cardiovascular events in patients with CAD and/or PAD.
Upon completion of this activity, participants will:
As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.
Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
Professor of Medicine
McMaster University
Hamilton, Ontario, Canada
Professor of Medicine and Biochemistry
McMaster University
Hamilton, Ontario, Canada
Professor of Cardiology and Angiology
Heart Center Freiburg University
Freiburg, Germany
Medscape, LLC staff have disclosed that they have no relevant financial relationships.
Peer Reviewer
This activity has been peer reviewed and the reviewer has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Abbott Laboratories.
Medscape, LLC designates this enduring material for a maximum of 0.50
AMA PRA Category 1 Credit(s)™
. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the
activity online during the valid credit period that is noted on the title page. To receive
AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print
out the tally as well as the certificates from the CME/CE Tracker.
*The credit that you receive is based on your user profile.
CME / ABIM MOC Released: 5/18/2020
Valid for credit through: 5/18/2021, 11:59 PM EST
processing....
ACEI = angiotensin-converting enzyme inhibitor
ACS = acute coronary syndrome
ALI = acute limb ischemia
ARB = angiotensin receptor blocker
ARR = absolute risk reduction
ASCVD = atherosclerotic cardiovascular disease
BARC = Bleeding Academic Research Consortium
CAD = coronary artery disease
CCS = chronic coronary syndrome
CHD = coronary heart disease
CLTI = chronic limb-threatening ischemia
CV = cardiovascular
CVD = cardiovascular disease
DAPT = dual antiplatelet therapy
DM = diabetes mellitus
DPI = dual pathway inhibition
DSMB = Data and Safety Monitoring Board
EASD = European Association for the Study of Diabetes
eGFR = estimated glomerular filtration rate
ESC = European Society of Cardiology
ESVM = European Society of Vascular Medicine
f/u = follow-up
GI = gastrointestinal tract
HTN = hypertension
ICH = intracranial hemorrhage
ISTH = International Society on Thrombosis and Haemostasis
KM = Kaplan-Meier
MACE = major adverse cardiac events
MACLE = major adverse cardiovascular and limb event
MALE = major adverse limb events
MI = myocardial infarction
NNH = number needed to harm
NNT = number needed to treat
NR = not reported
NSAID = nonsteroidal anti-inflammatory drug
PAD = peripheral artery disease
PAR = protease-activated receptor
PCI = percutaneous coronary intervention
PPI = proton pump inhibitor
RBC = red blood cell
RRR = relative risk reduction
TIA = transient ischemic attack
TIMI = Thrombolysis in Myocardial Infarction
VTE = venous thromboembolism
| « Return to: Factor Xa Inhibitors in CAD/PAD: Where Are We Today? |
